Allergen-mediated modulation of CD23 expression is interferon-γ and interleukin-10 dependent in allergic and non-allergic individuals

Clinical and Experimental Allergy

Volumn 33, Issue 11, 2003, Pages 1568-1575

  Roever, A C ^a   Heine, G ^a   Zuberbier, T ^a   Worm, M ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Dept of Dermatology and Allergy ^*  (Germany)

Author keywords

Birch pollen allergen; CD23 expression; IFN ; IL 10; sCD23; SIT

Indexed keywords

ALLERGEN; CD23 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 4; POLLEN ANTIGEN;

ALLERGY; ARTICLE; B LYMPHOCYTE; BIRCH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ALLERGENS; B-LYMPHOCYTES; BETULA; CELLS, CULTURED; CONJUNCTIVITIS, ALLERGIC; DOWN-REGULATION; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MONOCYTES; POLLEN; RECEPTORS, IGE; RHINITIS, ALLERGIC, SEASONAL;

EID: 0242552771     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01797.x     Document Type: Article

References (46)

1. Defrance T, Aubry JP, Rousset F et al. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med 1987; 165:1459-67.
2. Sarfati M, Fournier S, Wu CY, Delespesse G. Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol Res 1992; 11:260-72.
3. Wheeler DJ, Parveen S, Pollock K, Williams RJ. Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471. Immunology 1998; 95:105-10.
4. Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY. CD21 is a ligand for CD23 and regulates IgE production. Nature 1992; 358:505-7.
5. Bonnefoy JY, Lecoanet-Henchoz S, Gauchat JF et al. Structure and functions of CD23. Int Rev Immunol 1997; 16:113-28.
6. Mayer RJ, Bolognese BJ, Al-Mahdi N et al. Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice. Clin Exp Allergy 2000; 30:719-27.
7. Yabuuchi S, Nakamura T, Kloetzer WS, Reff ME. Anti-CD23 monoclonal antibody inhibits germline Cepsilon transcription in B cells. Int Immunopharmacol 2002; 2:453-61.
8. Sherr E, Macy E, Kimata H, Gilly M, Saxon A. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. J Immunol 1989; 142:481-9.
9. Cho S, Kilmon M, Studer E, van der Putten H, Conrad D. B Cell activation and Ig, especially IgE, production is inhibited by high CD23 levels in vivo and in vitro. Cellular Immunology 1997; 180:36-46.
10. Yu P, Kosco-Vilbois M, Richards M, Kohler G, Lamers MC. Negative feedback regulation of IgE synthesis by murine CD23. Nature 1994; 369:753-6.
11. Alesina R, De Amici M, Quaglini S, Puggioni F, Moratti R. CD23 during SIT. Allergy 2001; 56:917-8.
12. Yanagihara Y, Sarfati M, Marsh D, Nutman T, Delespesse G. Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE. Clin Exp Allergy 1990; 20:395-401.
13. + lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann Allergy 1992; 69:131-4.
14. + T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: evidence and regulation. Eur J Immunol 1994; 24:1109-14.
15. Gagro A, Rabatic S, Trescec A, Dekaris D, Medar-Lasic M. Expression of lymphocytes Fc epsilon RII/CD23 in allergic children undergoing hyposensitization. Int Arch Allergy Immunol 1993; 101:203-8.
16. Hakansson L, Heinrich C, Rak S, Venge P. Activation of B-lymphocytes during pollen season. Effect of immunotherapy [see comments]. Clin Exp Allergy 1998; 28:791-8.
17. Jung CM, Prinz JC, Rieber EP, Ring J. A reduction in allergen-induced Fc epsilon R2/CD23 expression on peripheral B cells correlates with successful hyposensitization in grass pollinosis. J Allergy Clin Immunol 1995; 95:77-87.
18. Roever AC, Henz BM, Worm M. Wasp-venom rush immunotherapy induces transient downregulation of B cell surface molecule expression. Int Arch Allergy Immunol 2002; 127:226-33.
19. Tulic MK, Manoukian JJ, Eidelman DH, Hamid Q. T-cell proliferation induced by local application of LPS in the nasal mucosa of nonatopic children. J Allergy Clin Immunol 2002; 110:771-6.
20. Akoum H, Tsicopoulos A, Vorng H et al. Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes. Immunology 1996; 87:593-8.
21. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997; 27:1131-9.
22. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154:4187-94.
23. Akdis CA, Blesken T, Wymann D, Akdis M, Blaser K. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Eur J Immunol 1998; 28:914-25.
24. Tinnell SB, Jacobs-Helber SM, Sterneck E, Sawyer ST, Conrad DH. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production. Int Immunol 1998; 10:1529-38.
25. Lee CE, Park HJ. Interleukin-4 induces two distinct GAS-binding complexes containing STAT6: evidence for DNA binding of STAT6 monomer. Mol Cells 2001; 11:28-34.
26. Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 1999; 19:563-73.
27. Bernabei P, Coccia EM, Rigamonti L et al. Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol 2001; 70:950-60.
28. Bach EA, Szabo SJ, Dighe AS et al. Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 1995; 270:1215-8.
29. Pernis A, Gupta S, Gollob KJ et al. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 1995; 269:245-7.
30. Kotenko SV, Pestka S. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 2000; 19:2557-65.
31. Frotscher B, Anton K, Worm M. Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors. J Invest Dermatol 2002; 119:1059-64.
32. Paterson RL, Lack G, Domenico JM et al. Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease. Eur J Immunol 1996; 26:1979-84.
33. Corominas M, Mestre M, Bas J, Buendia E. Distinct modulation by interferon-gamma (IFN-gamma) of CD23 expression on B and T lymphocytes of atopic subjects. Clin Exp Immunol 1998; 112:276-80.
34. Corominas M, Mestre M, Bas J et al. CD23 expression on B-lymphocytes and its modulation by cytokines in allergic patients. Clin Exp Allergy 1993; 23:612-7.
35. Lee CE, Yoon SR, Pyun KH. Mechanism of interferon-gamma down-regulation of the interleukin 4-induced CD23/Fc epsilon RII expression in human B cells: post-transcriptional modulation by interferon-gamma. Mol Immunol 1993; 30:301-7.
36. Alderson MR, Armitage RJ, Tough TW, Ziegler SF. Synergistic effects of IL-4 and either GM-CSF or IL-3 on the induction of CD23 expression by human monocytes: regulatory effects of IFN-alpha and IFN-gamma. Cytokine 1994; 6:407-13.
37. Kehry MR, Yamashita LC. Role of the low-affinity Fc epsilon receptor in B-lymphocyte antigen presentation. Res Immunol 1990; 141:77-81, discussion 105-8.
38. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
39. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102:98-106.
40. de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
41. Willems F, Marchant A, Delville JP et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24:1007-9.
42. Dugas N, Vouldoukis I, Becherel P et al. Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages. Eur J Immunol 1996; 26:1394-8.
43. Morinobu A, Kumagai S, Yanagida H et al. IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes. J Clin Immunol 1996; 16:326-33.
44. Spittler A, Schiller C, Willheim M, Tempfer C, Winkler S, Boltz-Nitulescu G. IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis. Immunology 1995; 85:311-7.
45. Ruzek MC, Billadeau D, Mathur A. A combination of IL-10 and direct contact with plasma cell tumors decreases CD23 expression on splenic B cells. J Immunol 1996; 156:2124-32.
46. +, CD62L-phenotype) and their contribution to the regulation of immunoglobulin E antibody formation. Int Arch Allergy Immunol 2002; 127:198-207.